TIANYIN PHARMACEUTICAL CO IN COM - 88630M104

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2014 · Q4 2013
Value (USD)
Total reported value ($000)
$3.029M
QoQ value delta ($000)
-$1.541M (-33.72%)
Implied price effect (QoQ)
+24.16%
Shares
Total shares
3,085,379
QoQ shares delta
-2,694,167 (-46.62%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Top holders (Q1 2014)

Top 25 only Full list
Early Q3 2021 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
POPE ASSET MANAGEMENT, LLC 2,244 2,284,900 1.29%
RENAISSANCE TECHNOLOGIES LLC 609 620,100 0.0%
KCG Holdings, Inc. 39 40,039 0.0%
CITADEL ADVISORS LLC 38 39,092 0.0%
Rotella Capital Management, Inc. 30 30,305 0.04%
Spark Investment Management LLC 25 25,900 0.0%
Regent Investment Management LLC 24 24,600 0.01%
CREDIT SUISSE AG/ 15 15,343 0.0%
Baltimore-Washington Financial Advisors, Inc. 5 5,100 0.0%